The DoD is working with the CDC and the Advisory Committee on Immunization Practices, a panel that advises the CDC, in responding to this vaccine delay. It is an implant designed to work with the natural structures of the middle ear to improve hearing and communication abilities for people with hearing impairment. Shortly after the Food and Drug Administration approved the device, a Navy retiree suffering from sensorineural hearing loss underwent the three-hour outpatient surgical implant procedure at the medical center. According to Capt. Lorenz F. Lassen, director of Surgical Services for NMCP and the operation's surgeon, making this innovative technology available enhances the quality of life for the military population suffering from hearing loss.
Hearing aids are a covered benefit for military personnel.
We incorporated this treatment alternative because it enhances communication by reducing feedback and providing better gain in high frequencies. Lassen explained that unlike conventional hearing aids, the new implant does not cover the ear canal, which significantly decreases the risk of moisture buildup and ear infections. Currently, NMCP provides about 300 sets of hearing aids per year to active duty patients. Lassen stated that only current hearing aid users would be considered for receiving an implant. I am unsure about how many of these hearing aid users would choose to have a surgical implant, but the number is probably between 20 to 30 percent, which means 60 to 90 patients per year.